{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:23:02Z","timestamp":1765966982248,"version":"3.48.0"},"reference-count":32,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CHDDT"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Acute lymphoblastic leukemia (ALL), a hematopoietic cancer of T or B\nlymphoblasts, is the most prevalent cancer in children. Ongoing research aims to better understand\nthe factors contributing to ALL and create more successful treatment options. Therefore,\nthe current study presented cytogenetic, genetic, and hematologic features from 318 ALL patients\nunder eighteen years of age who were referred to Ali Asghar Hospital of Tehran, Iran,\nfrom 2013 to 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study was designed as a retrospective cross-sectional analysis, focusing on 318\nchildren in Tehran, Iran, who had been newly diagnosed with ALL. All data were extracted from\nthe patient case files that included additional information, such as clinical data, and demographic\ninformation. The Flow cytometry technique was employed to perform immunophenotyping for\nvarious markers. Moreover, the standardized protocol was carried out for conventional cytogenetic\nanalysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Out of 318, 179 (56.3%) and 139 (43.7%) were males and females, respectively. The\nmost common subtype of ALL was Common B Cell ALL, accounting for 182 cases (57.23%),\nfollowed by Pre B cell ALL with 74 cases (23.27%) and T cell ALL with 27 cases (8.49%). Out\nof 222 patients, 17 (7.7%) had genetic abnormalities, with the highest incidence of abnormalities\nbeing associated with Runx 1 (four cases). Additionally, out of 228 patients, 143 (62.7%) were\nidentified as having cytogenetic abnormalities, with the most prevalent abnormalities being hyperdiploidy\n(54 cases) and t (12;21) (28 cases).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our findings showed that some cytogenetic abnormalities, such as t (9;22) and hyperdiploidy,\nwere consistent with previous studies. These results offer valuable foundational insights\nthat can help direct future research on ALL patients and inform potential treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/011871529x372625250606123726","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T03:44:34Z","timestamp":1750736674000},"page":"243-253","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic, Cytogenetic and Hematological Features in Newly Diagnosed Acute Lymphoid Leukemia Patients under Eighteen Years Age Referred to Ali Asghar Hospital of Tehran, Iran, from 2013 to 2023"],"prefix":"10.2174","volume":"25","author":[{"given":"Nafiseh","family":"Mortazavi","sequence":"first","affiliation":[{"name":"Aliasghar Clinical Research Development Center, Department of Pathology, School of Medicine, Iran University ofMedical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Eghbali","sequence":"additional","affiliation":[{"name":"Clinical Research Development Center of Aliasghar Hospital, Iran University of MedicalSciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid Kiani","family":"Ghalesardi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Blood Banking, School of Allied Medicine, Iran Universityof Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Afrisham","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences,Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Asadpouri","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology, Faculty of Medicine, AhvazJundishapur University of Medical Sciences, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Salehi","sequence":"additional","affiliation":[{"name":"Department of Health Information Management, School of HealthManagement and Information Sciences, Iran University of Medical Sciences, Tehran, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soudabeh","family":"Hosseini","sequence":"additional","affiliation":[{"name":"Department of Hematology and Blood Banking, School of Allied Medicine, Iran Universityof Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elahe Razmara","family":"Lak","sequence":"additional","affiliation":[{"name":"Clinical Research Development Center of Aliasghar Hospital, Iran University of MedicalSciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/cancers16050858","volume":"16","author":"He J.","year":"2024","unstructured":"He J.; Munir F.; Catueno S.; Connors J.S.; Gibson A.; Robusto L.; McCall D.; Nunez C.; Roth M.; Tewari P.; Garces S.; Cuglievan B.; Garcia M.B.; Biological markers of high-risk childhood acute lymphoblastic leukemia. Cancers  2024,16(5),858","journal-title":"Cancers"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.3390\/cancers13092256","volume":"13","author":"Tebbi C.K.","year":"2021","unstructured":"Tebbi C.K.; Etiology of acute leukemia: A review. Cancers  2021,13(9),2256","journal-title":"Cancers"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"Siegel R.L.","year":"2022","unstructured":"Siegel R.L.; Miller K.D.; Fuchs H.E.; Jemal A.; Cancer statistics, 2022. CA Cancer J Clin  2022,72(1),7-33","journal-title":"CA Cancer J Clin"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11864-020-00757-5","volume":"21","author":"Patel A.A.","year":"2020","unstructured":"Patel A.A.; Thomas J.; Rojek A.E.; Stock W.; Biology and treatment paradigms in T cell acute lymphoblastic leukemia in older adolescents and adults. Curr Treat Options Oncol  2020,21(7),57","journal-title":"Curr Treat Options Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1182\/blood-2002-12-3817","volume":"102","author":"Greaves M.F.","year":"2003","unstructured":"Greaves M.F.; Maia A.T.; Wiemels J.L.; Ford A.M.; Leukemia in twins: Lessons in natural history. Blood  2003,102(7),2321-2333","journal-title":"Blood"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0140-6736(71)92705-X","volume":"297","author":"Clarkson B.","year":"1971","unstructured":"Clarkson B.; Boyse E.; Possible explanation of the high concoddance for acute leukaemia in monozygotic twins. Lancet  1971,297(7701),699-701","journal-title":"Lancet"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/2040620713498161","volume":"4","author":"Stieglitz E.","year":"2013","unstructured":"Stieglitz E.; Loh M.L.; Genetic predispositions to childhood leukemia. Ther Adv Hematol  2013,4(4),270-290","journal-title":"Ther Adv Hematol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1046\/j.1365-2141.2001.03000.x","volume":"114","author":"Andersen M.K.","year":"2001","unstructured":"Andersen M.K.; Christiansen D.H.; Jensen B.A.; Ernst P.; Hauge G.; Pedersen-Bjergaard J.; Therapy\u2010related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: Report on two new cases and review of the literature since 1992. Br J Haematol  2001,114(3),539-543","journal-title":"Br J Haematol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41571-018-0136-6","volume":"16","author":"Pui C.H.","year":"2019","unstructured":"Pui C.H.; Nichols K.E.; Yang J.J.; Somatic and germline genomics in paediatric acute lymphoblastic leukaemia. Nat Rev Clin Oncol  2019,16(4),227-240","journal-title":"Nat Rev Clin Oncol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.leukres.2011.12.016","volume":"36","author":"Li X.","year":"2012","unstructured":"Li X.; Li J.; Hu Y.; Xie W.; Du W.; Liu W.; Li X.; Chen X.; Li H.; Wang J.; Zhang L.; Huang S.; A comprehensive cytogenetic classification of 1466 Chinese patients with de novo acute lymphoblastic leukemia. Leuk Res  2012,36(6),720-726","journal-title":"Leuk Res"},{"year":"2001","author":"Behjati F","key":"ref=11","unstructured":"Behjati F; Akbari MT; Chromosomal abnormalities in leukemia in Iran: A pilot study.  2001"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0188-4409(01)00260-0","volume":"32","author":"P\u00e9rez-Vera P.","year":"2001","unstructured":"P\u00e9rez-Vera P.; M\u00fajica-S\u00e1nchez M.; Carnevale A.; Rivera-Luna R.; Paredes R.; Mart\u00ednez A.; Fr\u00edas S.; Cytogenetics in acute lymphoblastic leukemia in Mexican children: An institutional experience. Arch Med Res  2001,32(3),202-207","journal-title":"Arch Med Res"},{"key":"ref=13","first-page":"301","volume":"38","author":"Safaei A.","year":"2013","unstructured":"Safaei A.; Shahryari J.; Farzaneh M.R.; Tabibi N.; Hosseini M.; Cytogenetic findings of patients with acute lymphoblastic leukemia in fars province. Iran J Med Sci  2013,38(4),301-307","journal-title":"Iran J Med Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s12288-019-01123-8","volume":"35","author":"Reddy P.","year":"2019","unstructured":"Reddy P.; Shankar R.; Koshy T.; Radhakrishnan V.; Ganesan P.; Jayachandran P.K.; Dhanushkodi M.; Mehra N.; Krupashankar S.; Manasa P.; Nagare R.P.; Swaminathan R.; Kannan K.; Sagar T.G.; Ganesan T.S.; Evaluation of cytogenetic abnormalities in patients with acute lymphoblastic leukemia. Indian J Hematol Blood Transfus  2019,35(4),640-648","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.20517\/2394-4722.2016.61","volume":"3","author":"Paridar M.","year":"2017","unstructured":"Paridar M.; Ghalesardi O.K.; Seghatoleslami M.; Ahmadzadeh A.; Khosravi A.; Saki N.; Cytogenetic and molecular basis of BCR-ABL myelodysplastic syndrome: Diagnosis and prognostic approach. J Cancer Metastasis Treat  2017,3(2),38-44","journal-title":"J Cancer Metastasis Treat"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1182\/blood.2021014309","volume":"139","author":"Akkari Y.M.N.","year":"2022","unstructured":"Akkari Y.M.N.; Baughn L.B.; Dubuc A.M.; Smith A.C.; Mallo M.; Dal Cin P.; Diez Campelo M.; Gallego M.S.; Granada Font I.; Haase D.T.; Schlegelberger B.; Slavutsky I.; Mecucci C.; Levine R.L.; Hasserjian R.P.; Sol\u00e9 F.; Levy B.; Xu X.; Guiding the global evolution of cytogenetic testing for hematologic malignancies. Blood  2022,139(15),2273-2284","journal-title":"Blood"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13039-021-00548-z","volume":"14","author":"Paridar M.","year":"2021","unstructured":"Paridar M.; Zibara K.; Ahmadi S.E.; Khosravi A.; Soleymani M.; Azizi E.; Ghalesardi O.K.; Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients. Mol Cytogenet  2021,14(1),24","journal-title":"Mol Cytogenet"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.34172\/aim.2021.34","volume":"24","author":"Rahimi Pordanjani S.","year":"2021","unstructured":"Rahimi Pordanjani S.; Kavousi A.; Mirbagheri B.; Shahsavani A.; Etemad K.; Geographical pathology of acute lymphoblastic leukemia in Iran with evaluation of incidence trends of this disease using Joinpoint regression analysis. Arch Iran Med  2021,24(3),224-232","journal-title":"Arch Iran Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.24875\/RIC.17002131","volume":"69","author":"Tlacuilo-Parra A.","year":"2017","unstructured":"Tlacuilo-Parra A.; Garibaldi-Covarrubias R.; Romo-Rubio H.; Soto-Sumuano L.; Ruiz-Ch\u00e1vez C.F.; Su\u00e1rez-Arredondo M.; S\u00e1nchez-Zubieta F.; Gallegos-Castorena S.; Geographical distribution and cluster detection of childhood leukemia in the metropolitan area of Guadalajara, Mexico. Rev Invest Clin  2017,69(3),159-165","journal-title":"Rev Invest Clin"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5455\/medarh.2019.73.311-315","volume":"73","author":"Bahoush G.","year":"2019","unstructured":"Bahoush G.; Nojoomi M.; Frequency of cytogenetic findings and its effect on the outcome of pediatric acute lymphoblastic leukemia. Med Arh  2019,73(5),311-315","journal-title":"Med Arh"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bjhh.2015.03.009","volume":"37","author":"Lustosa de Sousa D.W.","year":"2015","unstructured":"Lustosa de Sousa D.W.; de Almeida Ferreira F.V.; Cavalcante F\u00e9lix F.H.; de Oliveira Lopes M.V.; Acute lymphoblastic leukemia in children and adolescents: Prognostic factors and analysis of survival. Rev Bras Hematol Hemoter  2015,37(4),223-229","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref=22","first-page":"9","volume":"7","author":"Mehrvar A.","year":"2015","unstructured":"Mehrvar A.; Faranoush M.; Asl A.A.H.; Tashvighi M.; Fazeli M.A.; Mehrvar N.; Epidemiological features of childhood acute leukemia at MAHAK\u2019s Pediatric Cancer Treatment and Research Center (MPCTRC), Tehran, Iran.  2015,7(1),9-15"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5681\/hpp.2011.004","volume":"1","author":"Dastgiri S.","year":"2011","unstructured":"Dastgiri S.; Fozounkhah S.; Shokrgozar S.; Taghavinia M.; Asvadi Kermani A.; Incidence of leukemia in the northwest of iran. Health Promot Perspect  2011,1(1),50-53","journal-title":"Health Promot Perspect"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","volume":"51","author":"Gu Z.","year":"2019","unstructured":"Gu Z.; Churchman M.L.; Roberts K.G.; Moore I.; Zhou X.; Nakitandwe J.; Hagiwara K.; Pelletier S.; Gingras S.; Berns H.; Payne-Turner D.; Hill A.; Iacobucci I.; Shi L.; Pounds S.; Cheng C.; Pei D.; Qu C.; Newman S.; Devidas M.; Dai Y.; Reshmi S.C.; Gastier-Foster J.; Raetz E.A.; Borowitz M.J.; Wood B.L.; Carroll W.L.; Zweidler-McKay P.A.; Rabin K.R.; Mattano L.A.; Maloney K.W.; Rambaldi A.; Spinelli O.; Radich J.P.; Minden M.D.; Rowe J.M.; Luger S.; Litzow M.R.; Tallman M.S.; Racevskis J.; Zhang Y.; Bhatia R.; Kohlschmidt J.; Mr\u00f3zek K.; Bloomfield C.D.; Stock W.; Kornblau S.; Kantarjian H.M.; Konopleva M.; Evans W.E.; Jeha S.; Pui C.H.; Yang J.; Paietta E.; Downing J.R.; Relling M.V.; Zhang J.; Loh M.L.; Hunger S.P.; Mullighan C.G.; PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet  2019,51(2),296-307","journal-title":"Nat Genet"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fcell.2019.00137","volume":"7","author":"Raboso-Gallego J.","year":"2019","unstructured":"Raboso-Gallego J.; Casado-Garc\u00eda A.; Isidro-Hern\u00e1ndez M.; Vicente-Due\u00f1as C.; Epigenetic priming in childhood acute lymphoblastic leukemia. Front Cell Dev Biol  2019,7,137","journal-title":"Front Cell Dev Biol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1200\/JCO.2010.30.7405","volume":"29","author":"Pui C.H.","year":"2011","unstructured":"Pui C.H.; Carroll W.L.; Meshinchi S.; Arceci R.J.; Biology, risk stratification, and therapy of pediatric acute leukemias: An update. J Clin Oncol  2011,29(5),551-565","journal-title":"J Clin Oncol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1182\/blood-2012-06-437681","volume":"121","author":"Dastugue N.","year":"2013","unstructured":"Dastugue N.; Suciu S.; Plat G.; Speleman F.; Cav\u00e9 H.; Girard S.; Bakkus M.; Pag\u00e8s M.P.; Yakouben K.; Nelken B.; Uyttebroeck A.; Gervais C.; Lutz P.; Teixeira M.R.; Heimann P.; Ferster A.; Rohrlich P.; Collonge M.A.; Munzer M.; Luquet I.; Boutard P.; Sirvent N.; Karrasch M.; Bertrand Y.; Benoit Y.; Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results. Blood  2013,121(13),2415-2423","journal-title":"Blood"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"530","DOI":"10.4236\/jct.2016.77056","volume":"7","author":"Amare P.S.K.","year":"2016","unstructured":"Amare P.S.K.; Jain H.; Kabre S.; Deshpande Y.; Pawar P.; Banavali S.; Menon H.; Sengar M.; Arora B.; Khattry N.; Narula G.; Sarang D.; Kaskar S.; Bagal B.; Jain H.; Dangi U.; Subramanian P.G.; Gujral S.; Cytogenetic profile in 7209 Indian patients with de novo acute leukemia: A single centre study from India. J Cancer Ther  2016,7(7),530-544","journal-title":"J Cancer Ther"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/sj.leu.2402435","volume":"16","author":"Jabber Al-Obaidi M.S.","year":"2002","unstructured":"Jabber Al-Obaidi M.S.; Martineau M.; Bennett C.F.; Franklin I.M.; Goldstone A.H.; Harewood L.; Jalali G.R.; Prentice H.G.; Richards S.M.; Roberts K.; Harrison C.J.; ETV6\/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia  2002,16(4),669-674","journal-title":"Leukemia"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.3324\/haematol.2011.043919","volume":"96","author":"Grossmann V.","year":"2011","unstructured":"Grossmann V.; Kern W.; Harbich S.; Alpermann T.; Jeromin S.; Schnittger S.; Haferlach C.; Haferlach T.; Kohlmann A.; Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia. Haematologica  2011,96(12),1874-1877","journal-title":"Haematologica"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1038\/sj.onc.1207755","volume":"23","author":"Ito Y.","year":"2004","unstructured":"Ito Y.; Oncogenic potential of the RUNX gene family: \u2018Overview\u2019. Oncogene  2004,23(24),4198-4208","journal-title":"Oncogene"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1365-2567.2010.03381.x","volume":"132","author":"Wong W.F.","year":"2011","unstructured":"Wong W.F.; Kohu K.; Chiba T.; Sato T.; Satake M.; Interplay of transcription factors in T-cell differentiation and function: The role of Runx. Immunology  2011,132(2),157-164","journal-title":"Immunology"}],"container-title":["Cardiovascular &amp; Hematological Disorders-Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/011871529X372625250606123726","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/242818\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/011871529X372625250606123726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:16:04Z","timestamp":1765966564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/242818\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/011871529x372625250606123726","relation":{},"ISSN":["1871-529X"],"issn-type":[{"type":"print","value":"1871-529X"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-01-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}